pyrroles has been researched along with Carcinoma, Lewis Lung in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castiglioni, V; Cesca, M; Decio, A; Giavazzi, R; Rovida, A; Scanziani, E; Scarlato, V | 1 |
| D'Asti, E; Dombrovsky, A; Garnier, D; Lau, K; Magnus, N; Meehan, B; Rak, J | 1 |
| Choi, SH; Jang, J; Lee, HJ; Lee, YJ; Nam, JK | 1 |
| Cuccarese, MF; Dubach, JM; Engblom, C; Garris, C; Miller, MA; Pfirschke, C; Pittet, MJ; Weissleder, R | 1 |
| Chen, SH; Divino, CM; Kao, J; Ma, G; Meseck, M; Ozao-Choy, J; Pan, PY; Schwartz, M; Sung, M; Wang, GX | 1 |
| Donnelly, E; Geng, L; Hallahan, DE; Himmelfarb, E; McMahon, G; Mendel, D; Schueneman, AJ; Tan, J | 1 |
| Cao, C; Choy, H; Donnelly, E; Geng, L; Hallahan, DE; Lu, B; McMahon, G; Musiek, A; Tan, J | 1 |
| Fu, A; Geng, L; Hallahan, DE; Osusky, KL; Shyr, Y; Ye, F | 1 |
| Cuneo, KC; Fu, A; Geng, L; Osusky, KL | 1 |
| Cooke, JP; Glassford, AJ; Heeschen, C; Weis, M | 1 |
10 other study(ies) available for pyrroles and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Chemotherapy counteracts metastatic dissemination induced by antiangiogenic treatment in mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Movement; Cisplatin; Deoxycytidine; Doxorubicin; Gemcitabine; Humans; Indoles; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Paclitaxel; Protein Kinase Inhibitors; Pyrroles; Sunitinib; Topotecan | 2013 |
Ageing-related responses to antiangiogenic effects of sunitinib in atherosclerosis-prone mice.
Topics: Aging; Angiogenesis Inhibitors; Animals; Apolipoproteins E; Atherosclerosis; Carcinoma, Lewis Lung; Female; Indoles; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Transplantation; Pyrroles; Sunitinib; Treatment Outcome | 2014 |
Pirfenidone enhances the efficacy of combined radiation and sunitinib therapy.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Cell Line, Tumor; Collagen; Combined Modality Therapy; Indoles; Mice; Microvessels; Pyridones; Pyrroles; Radiation Tolerance; Sunitinib; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2015 |
Heterogeneity of macrophage infiltration and therapeutic response in lung carcinoma revealed by 3D organ imaging.
Topics: Aminopyridines; Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Cell Line, Tumor; Female; Humans; Imaging, Three-Dimensional; Lung; Lung Neoplasms; Macrophage Colony-Stimulating Factor; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Confocal; Microscopy, Fluorescence; Nanoparticles; Perfusion; Pyrroles; RAW 264.7 Cells; Receptors, Granulocyte-Macrophage Colony-Stimulating Factor; Signal Transduction; Tomography, X-Ray Computed; Treatment Outcome; Tumor Burden; Tumor Microenvironment; Xenograft Model Antitumor Assays | 2017 |
The novel role of tyrosine kinase inhibitor in the reversal of immune suppression and modulation of tumor microenvironment for immune-based cancer therapies.
Topics: Amino Acid Sequence; Animals; Carcinoma, Lewis Lung; Colonic Neoplasms; Indoles; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Molecular Sequence Data; Myeloid Cells; Protein Kinase Inhibitors; Pyrroles; Sunitinib; T-Lymphocytes, Regulatory | 2009 |
SU11248 maintenance therapy prevents tumor regrowth after fractionated irradiation of murine tumor models.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Combined Modality Therapy; Endothelium, Vascular; Glioblastoma; Humans; Indoles; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Neoplasms, Experimental; Neovascularization, Pathologic; Pyrroles; Receptor Protein-Tyrosine Kinases; Sunitinib | 2003 |
Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Activation; Humans; Indoles; Mice; Mice, Inbred C57BL; Oxindoles; Phosphorylation; Propionates; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrroles; Receptor Protein-Tyrosine Kinases | 2004 |
The receptor tyrosine kinase inhibitor SU11248 impedes endothelial cell migration, tubule formation, and blood vessel formation in vivo, but has little effect on existing tumor vessels.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blood Vessels; Carcinoma, Lewis Lung; Cell Movement; Cells, Cultured; Endothelium, Vascular; Humans; Indoles; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Secondary Prevention; Sunitinib; Umbilical Cord | 2004 |
Effects of vascular endothelial growth factor receptor inhibitor SU5416 and prostacyclin on murine lung metastasis.
Topics: Animals; Carcinoma, Lewis Lung; Cell Adhesion; Cells, Cultured; Disease Progression; Epoprostenol; Indoles; Liver Neoplasms; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasm Transplantation; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Splenic Neoplasms | 2007 |
Statins have biphasic effects on angiogenesis.
Topics: Animals; Apolipoproteins E; Apoptosis; Atorvastatin; Carcinoma, Lewis Lung; Cell Differentiation; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Growth Factors; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Lymphokines; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Neovascularization, Physiologic; Polyisoprenyl Phosphates; Pyridines; Pyrroles; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |